...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith related comments from GAC's Bloom Burton Experience

Quest, I respect where u r coming from, but give me resolution one way or the other on RVX and Zen and I am happy to move on unless I get new shares in a company run by a big pharma; plus in Canada I rather have capital gains taX- I could not take another 10 years of this management team. 

Share
New Message
Please login to post a reply